The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRuffer Regulatory News (RICA)

Share Price Information for Ruffer (RICA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 274.50
Bid: 273.00
Ask: 274.00
Change: 0.50 (0.18%)
Spread: 1.00 (0.366%)
Open: 278.00
High: 278.00
Low: 272.50
Prev. Close: 274.00
RICA Live PriceLast checked at -
Ruffer Investment Company is an Investment Trust

To achieve capital and income return of twice the Bank of England base rate by investing through internationally listed securities and bonds.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monthly Investment Report - November 2023

13 Dec 2023 07:00

RNS Number : 5590W
Ruffer Investment Company Limited
13 December 2023
 

RUFFER INVESTMENT COMPANY LIMITED

(a closed-ended investment company incorporated in Guernsey with registration number 41996)

LEI 21380068AHZKY7MKNO47

 

 

Attached is a link to the Monthly Investment Report for November 2023.

 

http://www.rns-pdf.londonstockexchange.com/rns/5590W_1-2023-12-12.pdf 

 

November proved to be a positive month for asset owners, as both bonds and equities rallied sharply. The catalyst was a growing hope that falling inflation will not be accompanied by slowing economic growth. This is an ideal outcome since it would allow policymakers to gently ease interest rates, helping to sustain high equity valuations without dampening earnings. Policymakers have also changed their tone, leaving investors less concerned about further monetary policy tightening.

 

The market moves were significant, with global bonds experiencing their best monthly return since 2008 and US equities recording their best monthly return this year. We added to the Company's bond duration in recent months to take advantage of compelling valuations (eg US ten year real yields reaching 2.5%), and with the belief that yields were reaching levels beyond which they would begin to cause acute pain to the financial system. The increased exposure enabled the Company to further benefit from November's rally in fixed income, which was the largest contributor to returns over the month. Likewise in equities, we had tactically added to the Company's exposure as risk assets struggled with rising yields in prior months. These increases to both bonds and equities enabled the portfolio to deliver a positive return and outweighed the headwinds from our protective assets. From a stock picking perspective, holdings in Ryanair, Coty and Jackson Financial were large positive contributors, alongside exposure to US banks Citi and EastWest.

 

On the negative side of the ledger, protective positions to guard against pain in the corporate bond market naturally suffered in the buoyant environment as credit spreads narrowed sharply. Elsewhere, exposure to energy was a headwind, partly as the perceived risk of wider military conflict across the Middle East has faded. Within our growth seeking assets, the exposure to Chinese equities continued to stutter. Whilst we deem the visit of Xi Jinping to San Francisco as a positive step in easing the tensions between the World's two largest powers, investor sentiment remains weak. We acknowledge there are good reasons for the high risk premium applied to Chinese equities, but it does stand out for both depressed valuations and, in our view, the increasing likelihood of further policy stimulus to come.

 

Given the speed of the rally across bonds and equities, we felt it was prudent to reduce the Company's exposures towards the end of the month. Bond markets are now pricing in over 1% of interest rate cuts in 2024 from the Federal Reserve. High equity valuations, tight credit spreads and low volatility suggest complacency may have returned to financial markets. There is a path for policymakers to pull off the magic trick of raising interest rates aggressively without derailing the economy, but we see an obvious vulnerability should events deviate from this narrow route. Policy changes feed through with a lag and the initial signs of a possible soft landing are eerily similar to those pre-empting something more severe. The Company's portfolio is designed to deliver positive returns in both benign conditions such as we saw this month, but also in those which are likely to be more challenging ahead.

 

Enquiries:

Sanne Fund Services (Guernsey) Limited

Jamie Dodd

Email: RIC@apexfs.group

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCNKBBDKBDBQBD
Date   Source Headline
12th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSKepler Trust Intelligence: New Research
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 202411:47 amRNSNet Asset Value(s)
1st Mar 202412:04 pmRNSNet Asset Value(s)
1st Mar 202410:34 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:01 amRNSDividend Declaration
29th Feb 20247:00 amRNSHalf-year Report
28th Feb 202412:11 pmRNSNet Asset Value(s)
28th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20248:09 amRNSTransaction in Own Shares
21st Feb 202410:52 amRNSNet Asset Value(s)
16th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 202411:46 amRNSNet Asset Value(s)
13th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares - replacement
8th Feb 20247:00 amRNSMonthly Investment Report - January 2024
7th Feb 20241:05 pmRNSNet Asset Value(s)
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 202411:30 amRNSNet Asset Value(s)
31st Jan 20242:55 pmRNSTotal Voting Rights
31st Jan 20241:36 pmRNSNet Asset Value(s)
31st Jan 20247:00 amRNSTransaction in Own Shares
30th Jan 20247:00 amRNSTransaction in Own Shares
29th Jan 20247:00 amRNSTransaction in Own Shares
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 202412:57 pmRNSNet Asset Value(s)
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
17th Jan 202412:22 pmRNSNet Asset Value(s)
17th Jan 20247:00 amRNSInvestment Manager's Period End Review
12th Jan 20247:00 amRNSMonthly Investment Report - December 2023
10th Jan 202411:22 amRNSNet Asset Value(s)
8th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 202412:50 pmRNSNet Asset Value(s)
3rd Jan 202410:09 amRNSNet Asset Value(s)
27th Dec 20232:50 pmRNSNet Asset Value(s)
20th Dec 20231:49 pmRNSNet Asset Value(s)
13th Dec 20234:15 pmRNSNet Asset Value(s)
13th Dec 20237:00 amRNSMonthly Investment Report - November 2023
6th Dec 20235:00 pmRNSNet Asset Value(s)
1st Dec 202310:42 amRNSNet Asset Value(s)
30th Nov 20234:33 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.